Neuropediatrics 2012; 43(05): 232-237
DOI: 10.1055/s-0032-1324398
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Outcome of Primary Childhood Central Nervous System Tumors: Results from a Single Center in Iran

Kh. Arjmandi Rafsanjani
1   Department of Pediatrics, Pediatric Hemato and Oncology, Ali-Asghar Children's Hospital, Tehran University of Medical Sciences, SIOP Member, Tehran, Islamic Republic of Iran
,
Gr. Bahoush
2   Department of Pediatrics, Pediatric Hemato and Oncologist, Onco-pathology Research Center, Ali-Asghar Children's Hospital, Tehran University of Medical Sciences, and SIOP Member, Tehran, Islamic Republic of Iran
,
F. Nikpoor
3   Ali-Asghar Children's Hospital, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
P. Vossough
4   Department of Pediatrics, Pediatric Hemato and Oncologist, Ali-Asghar Children's Hospital, Tehran University of Medical Sciences, SIOP Member, Tehran, Islamic Republic of Iran
› Institutsangaben
Weitere Informationen

Publikationsverlauf

17. Oktober 2011

23. Juni 2012

Publikationsdatum:
22. August 2012 (online)

Preview

Abstract

Background Childhood primary central nervous system (CNS) malignancies are one of the most important concerns in pediatric oncology.

Material In this historical cohort, 82 patients treated in Ali-Asghar Children's Hospital between 1996 and 2005 were evaluated for age, gender, type of treatment, tumor pathology, and survival.

Results The records of 38 female (46.3%) and 44 male (53.7%) patients were included. The mean age was 6.8 ± 3.39 years (6 months to 14 years); the frequency of medulloblastoma was significantly more than others (p = 0.012). Complete resection, radiotherapy, and chemotherapy were done in 47.5, 82.9, and 97.56%, respectively. Estimated 5 years overall and event-free survivals (EFSs) were approximately 68.5 and 35%, respectively. The patients with complete resected tumors had significantly better outcome (p = 0.013). Also, low-grade versus high-grade astrocytoma was significantly a better outcome (p = 0.01).

Conclusion The poor EFS with consideration of high number of progressive disease among our patients (50% unresectable tumor) suggests that children in Iran with CNS tumors had high quality of care but availability of advanced treatment protocol and sharing of cooperative trial study is essential for survival improvement. In addition to use more advanced methods and equipments of radiotherapy and chemotherapeutic drugs, we should seriously consider development of better surgical techniques to increase the rate of complete resection of malignant CNS tumors.